Applying systems thinking to identify enablers and challenges to scale-up interventions for hypertension and diabetes in low-income and middle-income countries: Protocol for a longitudinal mixed-methods study

Anusha Ramani-Chander, Rohina Joshi, Josefien Van Olmen, Edwin Wouters, Peter Delobelle, Rajesh Vedanthan, J. Jaime Miranda, Brian Oldenburg, Stephen Sherwood, Lal B. Rawal, Robert James Mash, Vilma Edith Irazola, Monika Martens, Maria Lazo-Porras, Hueiming Liu, Gina Agarwal, Gade Waqa, Milena Soriano Marcolino, Maria Eugenia Esandi, Antonio Luiz Pinho RibeiroAri Probandari, Francisco González-Salazar, Abha Shrestha, Sujarwoto Sujarwoto, Naomi Levitt, Myriam Paredes, Tomohiko Sugishita, Malek Batal, Yuan Li, Hassan Haghparast-Bidgoli, Violet Naanyu, Feng J. He, Puhong Zhang, Sayoki Godfrey Mfinanga, Jan Walter De Neve, Meena Daivadanam, Kamran Siddiqi, Pascal Geldsetzer, Kerstin Klipstein-Grobusch, Mark D. Huffman, Jacqui Webster, Dike Ojji, Andrea Beratarrechea, Maoyi Tian, Maarten Postma, Mayowa O. Owolabi, Josephine Birungi, Laura Antonietti, Zulma Ortiz, Anushka Patel, David Peiris, Darcelle Schouw, Jaap Koot, Keiko Nakamura, Gindo Tampubolon, Amanda G. Thrift

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction There is an urgent need to reduce the burden of non-communicable diseases (NCDs), particularly in low-and middle-income countries, where the greatest burden lies. Yet, there is little research concerning the specific issues involved in scaling up NCD interventions targeting low-resource settings. We propose to examine this gap in up to 27 collaborative projects, which were funded by the Global Alliance for Chronic Diseases (GACD) 2019 Scale Up Call, reflecting a total funding investment of approximately US$50 million. These projects represent diverse countries, contexts and adopt varied approaches and study designs to scale-up complex, evidence-based interventions to improve hypertension and diabetes outcomes. A systematic inquiry of these projects will provide necessary scientific insights into the enablers and challenges in the scale up of complex NCD interventions. Methods and analysis We will apply systems thinking (a holistic approach to analyse the inter-relationship between constituent parts of scaleup interventions and the context in which the interventions are implemented) and adopt a longitudinal mixed-methods study design to explore the planning and early implementation phases of scale up projects. Data will be gathered at three time periods, namely, at planning (T P), initiation of implementation (T 0) and 1-year postinitiation (T 1). We will extract project-related data from secondary documents at T P and conduct multistakeholder qualitative interviews to gather data at T 0 and T 1. We will undertake descriptive statistical analysis of T P data and analyse T 0 and T 1 data using inductive thematic coding. The data extraction tool and interview guides were developed based on a literature review of scale-up frameworks. Ethics and dissemination The current protocol was approved by the Monash University Human Research Ethics Committee (HREC number 23482). Informed consent will be obtained from all participants. The study findings will be disseminated through peer-reviewed publications and more broadly through the GACD network.

Original languageEnglish
Article numbere053122
JournalBMJ Open
Volume12
Issue number4
DOIs
Publication statusPublished - 18 Apr 2022

Bibliographical note

Funding Information:
Competing interests JvO reports Horizon2020 grants (643 692 and 825432) outside the submitted work. AGT declares funding from the National Health & Medical Research Council (NHMRC, Australia: GNT1042600, GNT1122455, GNT1171966, GNT1143155, GNT1182017), Stroke Foundation Australia (SG1807), and Heart Foundation Australia (VG102282) outside the submitted work. ML-P declares support from Fogarty International Centre, National Institutes of Health [R21TW009982], under the Global Alliance for Chronic Diseases (GACD) Diabetes ProgramProgramme. MEE reports grant funding from the Argentinian Ministry of Health (MoH) under the GACD program. AS declares funding from the Japan Agency for Medical Research & Development, as part of the GACD, outside the submitted work. FJH is partially funded by the National Institute for Health Research (NIHR) and the Medical Research Council (MRC), and is a member of the Action on Salt, and World Action on Salt, Sugar and Health (WASSH). AB declares grants from the MoH Argentina, National Institutes of Health, and World Diabetes Foundation, outside the submitted work. AP declares grant and fellowship support from the NHMRC outside the submitted work, Member of the Board of Directors, The George Institute India, and past Member of the Board of Directors, Heart Health Research Center, Beijing, PRC. RJ declares grant, outside the submitted work, from WHO Geneva, WHO South-East Asia Region (SEARO), Elrha Research for Health in Humanitarian Crises (R2HC), (Wellcome Trust, UK AID and NHS), DBT/ Wellcome Trust India Alliance and Gates Foundation. In the past 3 years, MDH has received research funding from American Heart Association, Verily, and AstraZeneca for research unrelated to this manuscript and has patents pending for heart failure polypills. The George Institute for Global Health has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines. None of the others authors has any conflict of interest to declare.

Funding Information:
Funding RJ is supported by the Australian National Heart Foundation (102059) and a UNSW Scientia Fellowship.

Publisher Copyright:
© 2022 Author(s). Published by BMJ.

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Applying systems thinking to identify enablers and challenges to scale-up interventions for hypertension and diabetes in low-income and middle-income countries: Protocol for a longitudinal mixed-methods study'. Together they form a unique fingerprint.

Cite this